<DOC>
	<DOCNO>NCT01689740</DOCNO>
	<brief_summary>This study examine symptom posttraumatic stress disorder ( PTSD ) people psychotherapy 25 mg follow two hour later 12.5 mg 125 mg follow two hour later 62.5 mg methylenedioxymethamphetamine ( MDMA ) order see treatment safe help reduce PTSD symptom . Participants randomly assign one two dos MDMA give two session schedule three five week apart . They prepare session first one work psychotherapists conventional ( non-drug assist ) psychotherapy afterwards . Symptoms PTSD depression , sleep quality general psychological health measure start study 2 12 month second session .</brief_summary>
	<brief_title>Randomized , Double-blind , Active-placebo Controlled Study MDMA-assisted Psychotherapy People With Chronic PTSD</brief_title>
	<detailed_description>Posttraumatic stress disorder ( PTSD ) debilitate disorder develop people undergo traumatic event , rape , car accident life-threatening event . PTSD worldwide health problem . Psychotherapy drug use treat PTSD , interest develop treatment option . 3,4-methylenedioxymethamphetamine ( MDMA ) -assisted psychotherapy one potential treatment . MDMA know active ingredient `` ecstasy . '' It use along psychotherapy treat people past , study suggest MDMA-assisted psychotherapy might help people PTSD . This Phase 2 research study investigate safety efficacy MDMA-assisted psychotherapy 10 people chronic , treatment-resistant posttraumatic stress disorder ( PTSD ) . After open-label lead-in two subject randomize , double-blind arm comparing 125 vs. 25 mg MDMA eight participant , open-label arm participant receive active placebo . In study , five people randomly assign receive full dose 125 62.5 mg MDMA three randomize receive active placebo dose 25 125. mg MDMA . MDMA administer two six eight hour long experimental session schedule three five week apart . Study subject medical psychiatric examination measure PTSD symptom make sure meet criterion study . Subjects must good physical health . They also complete questionnaire PTSD symptom , symptom depression sleep quality . These test give researcher present therapy session . This researcher give subject test measure two month second experimental session 12 month final experimental session . Once enrol , subject three preparatory session team two therapist , one male one female . The team therapists work throughout entire study . The subject learn MDMA-assisted psychotherapy therapist learn subject 's goal , hop fear . Starting second preparatory session , subject answer question thought hurt kill ; question ask face face contact two contact day , may occur telephone . Subjects stop take psychiatric medication first experimental session , exact time dependent upon specific medication involve . Both therapist present experimental session . During experimental session , subject encourage confront trauma-related thought , feeling memory . Blood pressure , heart rate ( pulse ) body temperature measure regularly , researcher periodically ask subject rate degree distress . Subjects stay overnight clinic first integrative session , examine happen experimental session . They two integrative session next experimental session . Subjects fill questionnaire PTSD symptom every third integrative session . Two month second experimental session , subject answer question complete questionnaire PTSD symptom , symptom depression sleep quality , one researcher assess general psychological function . Subjects therapist , person measure symptom , find subject active placebo full dose MDMA time , subject active placebo , start second arm study . What happen arm similar arm except subject therapist know subject get full dose MDMA . Twelve month subject 's final follow-up visit ( two month final experimental session ) , PTSD symptom , symptom depression sleep quality assess , subject complete additional questionnaire experience study . The study compare PTSD symptom MDMA-assisted psychotherapy full dose therapy active placebo dose MDMA .</detailed_description>
	<mesh_term>Stress Disorders , Traumatic</mesh_term>
	<mesh_term>Stress Disorders , Post-Traumatic</mesh_term>
	<mesh_term>N-Methyl-3,4-methylenedioxyamphetamine</mesh_term>
	<criteria>Diagnosed chronic PTSD duration 6 month longer ; Have CAPS score show moderate severe symptom least one unsuccessful attempt treatment PTSD either talk therapy drug , stop treatment inability tolerate psychotherapy drug therapy . Are least 18 year old Generally healthy Must sign medical release investigator communicate directly therapist doctor Are willing refrain take psychiatric medication study period agree , one week MDMA session , refrain taking unless prior approval research team : herbal supplement , nonprescription medication ( exception nonsteroidal antiinflammatory drug acetaminophen , prescription medication , exception birth control pill , thyroid hormone , medication ; Willing follow restriction guideline concern consumption food , beverage , nicotine night prior experimental session willing remain overnight study site willing contacted via telephone necessary telephone contact ; must negative pregnancy test able bear child , agree use effective form birth control ; Agree participate clinical trial duration clinical trial , include follow period ; Are proficient speak reading Hebrew ; Agree psychotherapy session record audio/video . Are pregnant nursing , woman child , practice effective mean birth control ; Weigh le 48 kg ; Are abuse illegal drug ; Are unable give adequate inform consent ; Upon review past current drugs/medication must take medication exclusionary . Upon review medical psychiatric history must current past diagnosis would consider risk participation study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>MDMA</keyword>
	<keyword>Posttraumatic stress disorder</keyword>
	<keyword>PTSD</keyword>
	<keyword>Israel</keyword>
	<keyword>psychotherapy</keyword>
</DOC>